Yidu Technology (02158) has spent more than HK$4.3 million on repurchases for 3 consecutive days

The Zhitong Finance App learned that Yidu Technology (02158) implemented share repurchases for 3 consecutive days, continuing to send positive signals. According to the company's announcement, on December 5, the company repurchased 280,000 shares at a price of HK$5.18 per share, with a repurchase amount of HK$1.4 million. It has been repurchased for 3 consecutive days, with a total repurchase amount of about 853,000 shares, with a cumulative repurchase amount of over HK$4.3 million.

According to the news, Yidu Technology recently released its 2026 interim results and held a performance conference. The report shows that during the reporting period, Yidu Technology's business maintained healthy growth, with total revenue reaching RMB 358 million, an increase of 8.7% over the previous year. The company's profit quality and operating efficiency have made a significant leap forward: the adjusted EBITDA of the current business is about RMB 54 million, which is double that of the same period last year, and the balance of profit and loss is almost at the level of accounting statements. This key financial milestone was reached about a year earlier than previously anticipated by the company's management.

Furthermore, today's news is that Beijing Tsinghua Chang Gung Hospital and Yidu Technology have officially launched the construction of a digital technology research and development platform and released the “Qingxin” ECG model, marking a new stage of cooperation between the two sides in the field of medical artificial intelligence.